BGM Group (NASDAQ:BGM) Trading Down 20.1% – Here’s What Happened

BGM Group Ltd. (NASDAQ:BGM)’s share price fell 20.1% on Monday . The stock traded as low as $0.2560 and last traded at $0.2750. 626,057 shares were traded during trading, an increase of 105% from the average session volume of 306,055 shares. The stock had previously closed at $0.3440.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d)” rating on shares of BGM Group in a report on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

BGM Group Price Performance

The business has a fifty day moving average of $0.48 and a 200 day moving average of $3.28.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC acquired a new position in BGM Group in the second quarter valued at approximately $412,000. Mariner LLC acquired a new position in BGM Group in the third quarter valued at approximately $267,000. Finally, Marshall Wace LLP acquired a new position in BGM Group in the second quarter valued at approximately $218,000.

About BGM Group

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.